[1] |
World Health Organization . Global tuberculosis report of 2017. Geneva: World Health Organization, 2017.
|
[2] |
Zetola NM, Shin SS, Tumedi KA , et al. Mixed Mycobacterium tuberculosis complex infections and false negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomes. J Clin Microbiol, 2014,52(7):2422-2429.
doi: 10.1128/JCM.02489-13
URL
|
[3] |
中国防痨协会基础专业委员会. 结核病诊断实验室检验规程. 北京: 中国教育文化出版社, 2006: 34-58.
|
[4] |
Siddiqi S, Ahmed A, Asif S , et al. Direct drug susceptibility testing of Mycobacterium tuberculosis for rapid detection of multidrug resistance using the bactec MGIT 960 system: a multicenter study. J Clin Microbiol, 2012,50(2):435-440.
doi: 10.1128/JCM.05188-11
URL
|
[5] |
李强, 包训迪, 刘元 , 等. MTBDRplus V2用于诊断涂阴疑似肺结核患者的效果评价. 中国防痨杂志, 2016,38(7):544-548.
|
[6] |
Blakemore R, Story E, Helb D , et al. Evaluation of the analytical performance of the XpertMTB/RIF assay. J Clin Microbiol, 2010,48(7):2495-2501.
doi: 10.1128/JCM.00128-10
URL
|
[7] |
Reddy R, Alvarez-Uria G . Molecular epidemiology of rifampicin resistance in Mycobacterium tuberculosis using the GeneXpert MTB/RIF assay from a rural setting in India. J Pathog, 2017,2017:6738095.
|
[8] |
Singh UB, Pandey P, Mehta G , et al. Genotypic, phenotypic and clinical validation of GeneXpert in extra-pulmonary and pulmonary tuberculosis in India. PLoS One, 2016,11(2):e0149258.
doi: 10.1371/journal.pone.0149258
URL
|
[9] |
路丽苹, 陆斌, 刘梅 , 等. GeneXpert MTB/RIF技术在结核病早诊断中的应用. 中国防痨杂志, 2017,39(1):71-75.
|
[10] |
牛海军, 王歌, 李明虎 . GeneXpert MTB/RIF检测在肺结核诊断中的价值评估. 中国防痨杂志, 2017,39(8):829-832.
|
[11] |
Li G, Zhang J, Guo Q , et al. Study of efflux pump gene expression in rifampicin-monoresistant Mycobacterium tuberculosis clinical isolates. J Antibiot (Tokyo), 2015,68(7):431-435.
doi: 10.1038/ja.2015.9
URL
|
[12] |
Cayci YT, Bilgin K, Coban AY , et al. An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF. Mem Inst Oswaldo Cruz, 2017,112(11):756-759.
doi: 10.1590/0074-02760170051
URL
|
[13] |
Williamson DA, Basu I, Bower J , et al. An evaluation of the Xpert MTB/RIF assay and detection of false-positive rifampicin resistance in Mycobacterium tuberculosis. Diagn Microbiol Infect Dis, 2011,74(2):207-209.
|
[14] |
Rigouts L, Gumusboga M, de Rijk WB ,et al. Rifampin resistance missed in automated liquid culture system for Mycobacterium tuberculosis isolates with specific rpoB mutations. J Clin Microbiol, 2013,51(8):2641-2645.
doi: 10.1128/JCM.02741-12
URL
|
[15] |
Van Deun A, Aung KJ, Bola V , et al. Rifampin drug resistance tests for tuberculosis: challenging the gold standard. J Clin Microbiol, 2013,51(8):2633-2640.
doi: 10.1128/JCM.00553-13
URL
|
[16] |
Ocheretina O, Byrt E, Mabou MM , et al. False-positive rifampin resistant results with Xpert MTB/RIF version 4 assay in clinical samples with a low bacterial load. Diagn Microbiol Infect Dis, 2016,85(1):53-55.
doi: 10.1016/j.diagmicrobio.2016.01.009
URL
|
[17] |
Chiang TY, Fan SY, Jou RW . Performance of an Xpert-based diagnostic algorithm for the rapid detection of drug resistant tuberculosis among high-risk populations in a low-incidence setting. PLoS One, 2018,13(7):e0200755.
doi: 10.1371/journal.pone.0200755
URL
|